Elevated Aspartate Aminotransferase to Platelet Ratio Index Associated With Dyslipidaemia and Obesity in Patients With Polycystic Ovary Syndrome

Current evidence-based international guidelines emphasise that PCOS is not an isolated condition but a systemic endocrine disorder that requires multidisciplinary management. Metabolic abnormalities and indicators of cardiovascular disease risk can be assessed non-invasively in women with PCOS, one of the world's most important health problems. At the same time, patients at risk can be followed more closely and carefully. Given that metabolic risks vary by phenotype and region, personalised assessment and management are essential.